SEC Form 4 · accession 0001144204-15-038888
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael W George
Director
Period of report
Feb 13, 2015
Accepted (ET)
Jun 24, 2015 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF4,F3 | — | Feb 13, 2015 | A | 1,847 | A | — | — | Common Stock | 1,847 | 1,847 | D |
| Phantom StockF4,F3 | — | May 15, 2015 | A | 1,176 | A | — | — | Common Stock | 1,176 | 1,176 | D |
| Stock Option (right to buy)F1 | $2.11 | holding | — | — | — | — | Apr 5, 2024 | Common Stock | 15,000 | 15,000 | D |
| Stock Option (right to buy)F2 | $2.79 | holding | — | — | — | — | Feb 27, 2024 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (right to buy)F2 | $5.62 | holding | — | — | — | — | Mar 1, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F15,000 vest upon completion of an April 2014 milestone; 10,000 vest upon completion of another milestone by the third quarter of 2014.
- F2These options vest in full on the first anniversary of the date of grant.
- F3Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
- F4These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of directors fees.